ChartMill assigns a Buy % Consensus number of 68% to XRAY. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-20 | Mizuho | Maintains | Neutral -> Neutral |
| 2026-01-05 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-12-16 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-12-16 | Baird | Maintains | Neutral -> Neutral |
| 2025-12-09 | Barclays | Initiate | Underweight |
| 2025-11-10 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-11-07 | William Blair | Downgrade | Outperform -> Market Perform |
| 2025-11-07 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-07 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-10-29 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-10-28 | UBS | Maintains | Buy -> Buy |
| 2025-10-08 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-09-26 | Needham | Reiterate | Hold -> Hold |
| 2025-08-08 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-08-08 | UBS | Maintains | Buy -> Buy |
| 2025-08-08 | Stifel | Maintains | Hold -> Hold |
| 2025-08-08 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-22 | Barrington Research | Reiterate | Outperform -> Outperform |
| 2025-07-21 | Needham | Reiterate | Hold -> Hold |
| 2025-05-12 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-05-09 | UBS | Maintains | Buy -> Buy |
| 2025-04-30 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-03-13 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-03-13 | Needham | Downgrade | Buy -> Hold |
| 2025-02-28 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-02-28 | Needham | Maintains | Buy -> Buy |
| 2025-02-28 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-28 | Baird | Maintains | Neutral -> Neutral |
| 2025-02-14 | Wells Fargo | Initiate | Equal-Weight |
| 2025-02-11 | Needham | Reiterate | Buy -> Buy |
22 analysts have analysed XRAY and the average price target is 12.86 USD. This implies a price increase of 1.01% is expected in the next year compared to the current price of 12.73.
The consensus rating for DENTSPLY SIRONA INC (XRAY) is 68.1818 / 100 . This indicates that analysts generally have a neutral outlook on the stock.